SCHEMBL4459423

SCHEMBL4459423

CC(Nc1ccccc1)C(=O)O.O=CCCl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ LMNA P02545 3/20 0.42
▸ TSHR P16473 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ ALOX12 P18054 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ HPGD P15428 2/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ GAA P10253 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1531678 0.86 TDP1 (0.56) TDP1ALDH1A1LMNATSHRCYP3A4
SCHEMBL33928 0.86 TDP1 (0.56) TDP1ALDH1A1LMNATSHRCYP3A4
SCHEMBL1331551 0.86 TDP1 (0.56) TDP1ALDH1A1LMNATSHRCYP3A4
SCHEMBL1330911 0.86 TDP1 (0.56) TDP1ALDH1A1LMNATSHRCYP3A4
SCHEMBL33927 0.86 TDP1 (0.56) TDP1ALDH1A1LMNATSHRCYP3A4
SCHEMBL7468986 0.84 TDP1 (0.54) TDP1ALDH1A1LMNATSHRCYP3A4
SCHEMBL7073966 0.84 TDP1 (0.54) TDP1ALDH1A1LMNATSHRCYP3A4
Hydrochloric Acid SCHEMBL10445714 0.84 TDP1 (0.54) TDP1ALDH1A1LMNATSHRCYP3A4
SCHEMBL2584998 0.84 TDP1 (0.54) TDP1ALDH1A1LMNATSHRCYP3A4
Methane SCHEMBL6442579 0.84 TDP1 (0.54) TDP1ALDH1A1LMNATSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781267-A4 METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS COMBINATORX INC (US) 2009-03-11 — — EP disclosed
EP-1781267-A2 METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS Combinatorx, Incorporated (US) 2007-05-09 — — EP disclosed
WO-2005115455-A2 METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS COMBINATORX, INCORPORATED (US) 2005-12-08 — — WO disclosed
Send feedback